During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost sat down with Jean-Luc Marsat, CEO & Chairman at EverImmune, to discuss the research EverImmune carries out in oncology.
Live Biotherapeutics as cancer treatments: scientific and regulatory challenges
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Most recent
Scientific research
22 July 2024
HCPs Area
Industry
- Read more about gut microbiota, LBP
Scientific research
22 July 2024
Industry
18 July 2024
Gastroenterology
15 July 2024
